Estrogen/medroxyprogesterone reduces fracture risk

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1408, 2003-01, pp. : 16-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Zoledronic acid reduces fracture risk . . .

By  

Inpharma, Vol. 1, Iss. 1587, 2007-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Teriparatide reduces fracture risk in postmenopausal osteoporosis

By  

Inpharma, Vol. 1, Iss. 1288, 2001-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Medroxyprogesterone: increased risk of cervical infections

By  

Inpharma, Vol. 1, Iss. 1460, 2004-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Estrogen alone or combined with medroxyprogesterone but not raloxifene reduce myocardial infarct size

By Sbarouni E.   Iliodromitis E.K.   Bofilis E.   Kyriakides Z.S.   Kremastinos D.T.  

European Journal of Pharmacology, Vol. 467, Iss. 1, 2003-04 ,pp. : 163-168

Elsevier

Access to resources Recommend Favorite

Depot medroxyprogesterone increases risk of cardiovascular disease?

By  

Inpharma, Vol. 1, Iss. 1355, 2002-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite